Impella 2.5 in a patient with left main coronary artery occlusion

Short-term assist devices have been indicated in many clinical settings mostly as a bridge to the next step. In this article, we report a case of cardiogenic shock due to acute occlusion of left main coronary artery who was scheduled to be transferred from Iran to Germany for the next treatment (permanent assist device implantation). Impella 2.5 (Abiomed Inc., Danvers, MA, USA), a short-term assist device, made the long distance journey possible. <Learning objective: Managing of severe cardiogenic shock by early revascularization and prompt installation of mechanical circulatory support in peripheral hospital as bridge to decision and successful long-distance transfer on mechanical circulatory support.>.